dc.description.abstract |
Antimicrobial resistance is one of our most series health problems. Infections from resistance
bacteria are now common, and some pathogens have been become resistant to multiple classes of
antibiotics. Transition metal based drug represents a promising approach of antibacterial agent
with potential application for inhibition of bacterial infectious diseases. Consequently, in this
study Iron (II) new complexes of the ligand bitartrate [Fe(HTA)(H2O)4]Cl and mixed ligand
complex of 2,2’-Bipyridine [Fe(HTA)(Bpy)(H2O)2]Cl were synthesized. The structures of the
complexes were characterized using various analytical, thermal and spectroscopic techniques,
particularly using UV-Vis and FT-IR. Furthermore, the synthesized metal complexes were
evaluated for their in vitro antibacterial activity against Gram-positive (staphylococcus aurous,
Staphylococcus epidermidis) and Gram-negative (Escherichia coli, and Klebsiella Pneumonia)
bacteria by Disc Diffusion method and their antimicrobial activity were compared with the
standard commercial drug TTC. The final complexes showed good antimicrobial activity
towards Staphylococcus empidermidis and Escherichia coli.
Keywords: Bitartrate, 2, 2’-Bipyridine, mixed ligand complex, antibacterial activity, iron (II |
en_US |